UA96427C2 - Substituted pyrazole compounds - Google Patents

Substituted pyrazole compounds

Info

Publication number
UA96427C2
UA96427C2 UAA200805165A UAA200805165A UA96427C2 UA 96427 C2 UA96427 C2 UA 96427C2 UA A200805165 A UAA200805165 A UA A200805165A UA A200805165 A UAA200805165 A UA A200805165A UA 96427 C2 UA96427 C2 UA 96427C2
Authority
UA
Ukraine
Prior art keywords
pyrazole compounds
substituted pyrazole
aurora
disclosed
inhibitors
Prior art date
Application number
UAA200805165A
Other languages
Russian (ru)
Inventor
Сяо-и Сяо
Диниш В. Пейтел
Джон С. Уорд
Марк Р. Брей
Грегори Э. Агостон
Энтони М. Трестон
Original Assignee
Мийкана Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мийкана Терапьютикс, Инк. filed Critical Мийкана Терапьютикс, Инк.
Publication of UA96427C2 publication Critical patent/UA96427C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.
UAA200805165A 2005-09-30 2006-09-29 Substituted pyrazole compounds UA96427C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72221705P 2005-09-30 2005-09-30

Publications (1)

Publication Number Publication Date
UA96427C2 true UA96427C2 (en) 2011-11-10

Family

ID=40107303

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200805165A UA96427C2 (en) 2005-09-30 2006-09-29 Substituted pyrazole compounds

Country Status (3)

Country Link
CN (1) CN101316587B (en)
UA (1) UA96427C2 (en)
ZA (1) ZA200802786B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201034675A (en) * 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration
WO2013143466A1 (en) * 2012-03-27 2013-10-03 广东东阳光药业有限公司 Substituted pyrimidine derivative as aurora kinase inhibitor
CN111349076B (en) * 2018-12-20 2022-07-26 江苏恒瑞医药股份有限公司 Crystal form of L-lysine salt of benzopiperidine derivative and preparation method thereof
CN115925684A (en) * 2021-12-03 2023-04-07 徐诺药业(南京)有限公司 Pyrimidine derivative and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE294797T1 (en) * 2000-09-15 2005-05-15 Vertex Pharma PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS
PL210066B1 (en) * 2000-12-21 2011-11-30 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
WO2004037814A1 (en) * 2002-10-25 2004-05-06 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors

Also Published As

Publication number Publication date
CN101316587B (en) 2013-04-03
CN101316587A (en) 2008-12-03
ZA200802786B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
WO2007041358A3 (en) Substituted pyrazole compounds
TW200801008A (en) Protein kinase inhibitors
WO2006055831A3 (en) Kinase inhibitors
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
MX2009005011A (en) Imidazopyrazines as protein kinase inhibitors.
MXPA06010904A (en) Tricyclic pyrazole kinase inhibitors.
MX2007003603A (en) Methods for preparing indazole compounds.
MX2009013729A (en) Imidazopyrazines as protein kinase inhibitors.
MX2009002377A (en) Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase.
UA95934C2 (en) Pyridiazinone derivatives for tumour treatment
WO2009064486A3 (en) Inhibitors of pim protein kinases, compositions, and methods for treating cancer
MX2009011810A (en) Thiazoles and pyrazoles useful as kinase inhibitors.
GEP20125368B (en) Kinase inhibitors
WO2006050109A3 (en) Novel kinase inhibitors
UA101478C2 (en) Compounds useful as inhibitors of raf protein kinase
MX2009012719A (en) Thiazoles and pyrazoles useful as kinase inhibitors.
IL173348A0 (en) Thienopyridine and furopyridine kinase inhibitors
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
ATE432281T1 (en) PYRROLOTRIAZINE KINASE INHIBITORS
MX2010006203A (en) Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases.
TW200621721A (en) Methods of preparing indazole compounds
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2008001538A (en) 2-aminoaryl pyridines as protein kinases inhibitors.
CA2641347C (en) Indazole-heteroaryl derivatives
MX2009004771A (en) Tricyclic heteroaryl compounds useful as inhibitors of janus kinase.